The Globe and Mail
🏢 Globe and Mail Inc. (Woodbridge)
Jul 29, 2026
· 6 min read
AI Analyzed
○ Unverifiable
View full audit trail →
Apotex emerges as only supplier of generic Ozempic in Canada for now
Original article ↗ 🔒 Paywalled source — limited preview availableB.I.A.S. ANALYSIS
CENTER
LEFTCENTERRIGHT
Signal breakdown
Heuristic (v1/v3)
0.50 · CENTER
ML v2 (DistilBERT)
0.000 · CENTER
Ensemble
0.000 · CENTER
🏦 Source Intelligence
Rolling outlet bias
CENTER
avg -0.060
8,494 articles tracked
7-day bias trend
LcenterR
V.E.R.I.F.Y. has fact-checked this article.
Subscribe to see claim-by-claim verdicts and reasoning.
Subscribe to see claim-by-claim verdicts and reasoning.
Article Excerpt
Apotex emerges as only supplier of generic Ozempic in Canada for now
CHRIS HANNAY
PUBLISHED 1 HOUR AGO
1 COMMENTS
SHARE
SAVE FOR LATER
Listen to this article
Learn more about audio
Log in or create a free account to listen to this article.
Key takeaways
This summary is AI-generated and editor reviewed. Learn more
Apotex Health Corp. is now Canada’s only supplier of generic semaglutide after a manufacturing defect at an Indian facility sidelined competitors Dr. Reddy’s Laboratories and Aspen Pharmacare.
Dr. Reddy’s CEO said impurities were found at the facility and fixes won’t be complete…
Read full article at The Globe and Mail ↗
How we scored this article
WTF uses a two-tier system: every article gets a heuristic bias score from keyword analysis, and priority articles (high overlap across 3+ outlets or strong heuristic signal) get full LLM analysis from B.I.A.S. and V.E.R.I.F.Y.
Analyzed by
B.I.A.S.
V.E.R.I.F.Y.
L.O.C.A.L.
quick v1 + full
Jul 29, 2026